Published Date: 11-11-2016
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Asia Pacific Defibrillators Market is expected to grow at a CAGR of 9.2% CAGR during 2016 - 2022. The China market dominated the Asia Pacific Defibrillators Market in 2015 and would continue till 2022, growing at a CAGR of 9.7 % during the forecast period.
The India market would witness the high growth rate of 11.2 % during 2016-2022. The Implantable Cardioverter Defibrillators (ICD) market dominated the Asia Pacific Defibrillators Market in 2015 and would grow at a CAGR of 10.2% CAGR during 2016 - 2022. The Advanced Life Support (ALS) Defibrillators market is poised to attain a market value of $ 1,077.1 Million by 2022.
The Hospitals segment dominated the Asia Pacific Defibrillators market and attained a market size of $2,253.7 Million in 2015 and is expected to grow at a CAGR of 8.6 % CAGR during 2016 - 2022. The Pre-hospitals segment would attain a market size of $295.9 Million by 2022. The Public Access Markets segment would grow at a CAGR of 11.6% during the forecast period.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
The market is segmented based on product type, end use, and country.